Schedule 13D ownership disclosure

Spark Therapeutics, Inc.

Security class unavailable · CUSIP: 84652J103

Event date: 2016-06-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,838,910
Percent of class
22.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-131016
Form type
SC 13D/A
Filer
Children's Hospital of Philadelphia Foundation
CIK
CIK 1632060
Filed
Jul 05, 2016
Reporting period
Jun 20, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub